STOCK TITAN

Minerva reports 5.3% InfuSystem (INFU) stake in Schedule 13G/A

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Minerva Advisors LLC and related entities report owning 1,078,731 shares of InfuSystem Holdings common stock, representing 5.3% of the company’s outstanding shares. The ownership is reported on a Schedule 13G/A as of 12/31/2025 and is based on 20,336,183 shares outstanding as of October 31, 2025.

The stake is held across Minerva Advisors LLC, Minerva Group, LP, Minerva GP, LP, Minerva GP, Inc., and David P. Cohen, with 764,517 shares held by Minerva Group, LP. The filers certify the securities are not held for the purpose of changing or influencing control, other than activities solely in connection with a nomination under Rule 14a-11.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Minerva Advisors LLC
Signature:David P. Cohen
Name/Title:President
Date:02/17/2026
MINERVA GROUP LP
Signature:David P. Cohen
Name/Title:Managing Partner
Date:02/17/2026
MINERVA GP, LP
Signature:David P. Cohen
Name/Title:General Partner
Date:02/17/2026
MINERVA GP, INC.
Signature:David P. Cohen
Name/Title:President
Date:02/17/2026
COHEN DAVID P
Signature:David P. Cohen
Name/Title:Individual
Date:02/17/2026

FAQ

What stake in InfuSystem Holdings (INFU) does Minerva report on this Schedule 13G/A?

Minerva Advisors LLC and related entities report beneficial ownership of 1,078,731 InfuSystem common shares, equal to 5.3% of the outstanding stock, based on 20,336,183 shares outstanding as of October 31, 2025, as disclosed in InfuSystem’s Form 10-Q.

Which Minerva entities are listed as reporting persons for InfuSystem (INFU)?

The filing lists five reporting persons: Minerva Advisors LLC, Minerva Group, LP, Minerva GP, LP, Minerva GP, Inc., and individual David P. Cohen. Each is deemed a beneficial owner of 764,517 shares held by Minerva Group, LP, with Minerva Advisors and Cohen each reporting 1,078,731 shares.

How much of InfuSystem’s (INFU) stock does each Minerva entity beneficially own?

Minerva Advisors LLC and David P. Cohen each report beneficial ownership of 1,078,731 shares, or 5.3% of InfuSystem’s common stock. Minerva Group, LP, Minerva GP, LP, and Minerva GP, Inc. each report 764,517 shares, or 3.8% of the outstanding common stock, all tied to Minerva Group’s holdings.

What voting and dispositive powers over InfuSystem (INFU) shares does Minerva report?

The filing states 764,517 shares with sole voting and dispositive power for Minerva Group, LP and related entities. Minerva Advisors LLC and David P. Cohen also report shared voting and dispositive power over 314,214 shares, reflecting additional shares beneficially owned through Minerva Advisors LLC.

Is Minerva’s InfuSystem (INFU) stake intended to change control of the company?

The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of InfuSystem. It notes an exception only for activities solely in connection with a nomination under Rule 240.14a-11, consistent with a passive investment filing on Schedule 13G.
Infusystem Hld

NYSE:INFU

INFU Rankings

INFU Latest News

INFU Latest SEC Filings

INFU Stock Data

157.61M
18.90M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
ROCHESTER HILLS